Role of the Oral and Maxillofacial Surgeon in the Diagnosis and Treatment of Patients with Osteoporosis

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Because of the increasing prevalence of osteoporosis in the aging population, it is important for oral surgeons to be aware of this condition. Oral health frequently reflects systemic diseases, and calcium loss in the teeth may mirror systemic mineral losses in the skeleton. Chronic health conditions, such as osteoporosis, also may affect surgical outcomes. In the past, therapies of osteoporosis were limited to hormonal replacement therapy and fluoride. Recently, there has been a proliferation of new therapies for osteoporosis that may affect dental health. The association between bisphosphonate use and osteonecrosis of the jaw is of concern. It is important that oral surgeons be aware of the medications a patient is using for the treatment of osteoporosis before initiating any procedure.

Original languageEnglish (US)
Pages (from-to)475-485
Number of pages11
JournalOral and Maxillofacial Surgery Clinics of North America
Volume19
Issue number4
DOIs
StatePublished - Nov 1 2007

Fingerprint

Osteoporosis
Bisphosphonate-Associated Osteonecrosis of the Jaw
Therapeutics
Tooth Loss
Health
Oral Health
Jaw
Fluorides
Skeleton
Minerals
Tooth
Oral and Maxillofacial Surgeons
Calcium
Population

ASJC Scopus subject areas

  • Surgery
  • Oral Surgery
  • Otorhinolaryngology

Cite this

@article{9f32de2c36104d1197d3cd875d68eb8c,
title = "Role of the Oral and Maxillofacial Surgeon in the Diagnosis and Treatment of Patients with Osteoporosis",
abstract = "Because of the increasing prevalence of osteoporosis in the aging population, it is important for oral surgeons to be aware of this condition. Oral health frequently reflects systemic diseases, and calcium loss in the teeth may mirror systemic mineral losses in the skeleton. Chronic health conditions, such as osteoporosis, also may affect surgical outcomes. In the past, therapies of osteoporosis were limited to hormonal replacement therapy and fluoride. Recently, there has been a proliferation of new therapies for osteoporosis that may affect dental health. The association between bisphosphonate use and osteonecrosis of the jaw is of concern. It is important that oral surgeons be aware of the medications a patient is using for the treatment of osteoporosis before initiating any procedure.",
author = "Isales, {Carlos M}",
year = "2007",
month = "11",
day = "1",
doi = "10.1016/j.coms.2007.06.003",
language = "English (US)",
volume = "19",
pages = "475--485",
journal = "Oral and Maxillofacial Surgery Clinics of North America",
issn = "1042-3699",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Role of the Oral and Maxillofacial Surgeon in the Diagnosis and Treatment of Patients with Osteoporosis

AU - Isales, Carlos M

PY - 2007/11/1

Y1 - 2007/11/1

N2 - Because of the increasing prevalence of osteoporosis in the aging population, it is important for oral surgeons to be aware of this condition. Oral health frequently reflects systemic diseases, and calcium loss in the teeth may mirror systemic mineral losses in the skeleton. Chronic health conditions, such as osteoporosis, also may affect surgical outcomes. In the past, therapies of osteoporosis were limited to hormonal replacement therapy and fluoride. Recently, there has been a proliferation of new therapies for osteoporosis that may affect dental health. The association between bisphosphonate use and osteonecrosis of the jaw is of concern. It is important that oral surgeons be aware of the medications a patient is using for the treatment of osteoporosis before initiating any procedure.

AB - Because of the increasing prevalence of osteoporosis in the aging population, it is important for oral surgeons to be aware of this condition. Oral health frequently reflects systemic diseases, and calcium loss in the teeth may mirror systemic mineral losses in the skeleton. Chronic health conditions, such as osteoporosis, also may affect surgical outcomes. In the past, therapies of osteoporosis were limited to hormonal replacement therapy and fluoride. Recently, there has been a proliferation of new therapies for osteoporosis that may affect dental health. The association between bisphosphonate use and osteonecrosis of the jaw is of concern. It is important that oral surgeons be aware of the medications a patient is using for the treatment of osteoporosis before initiating any procedure.

UR - http://www.scopus.com/inward/record.url?scp=35348827273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348827273&partnerID=8YFLogxK

U2 - 10.1016/j.coms.2007.06.003

DO - 10.1016/j.coms.2007.06.003

M3 - Review article

C2 - 18088899

AN - SCOPUS:35348827273

VL - 19

SP - 475

EP - 485

JO - Oral and Maxillofacial Surgery Clinics of North America

JF - Oral and Maxillofacial Surgery Clinics of North America

SN - 1042-3699

IS - 4

ER -